Cost-utility analysis of cholinesterase inhibitors in the treatment of mild to moderate Alzheimer's disease

Suggested Citation

Saowalak Turongkaravee Cost-utility analysis of cholinesterase inhibitors in the treatment of mild to moderate Alzheimer's disease. Thesis (M.Sc. (Pharmacy Administration))--Mahidol University, 2008. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/96646

Availability